Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9078911 Antisense oligonucleotides

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 8, 2012
Date of Patent
July 14, 2015
Patent Application Number
13369050
Patent Citations Received
‌
US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies
0
‌
US Patent 12064483 Nucleic acid-polypeptide compositions and methods of inducing exon skipping
0
‌
US Patent 12071621 Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
0
‌
US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 11679161 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 11771776 Muscle targeting complexes and uses thereof for treating dystrophinopathies
‌
US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness
‌
US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 11872287 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9078911
Patent Primary Examiner
‌
Jon E. Angell

Find more entities like US Patent 9078911 Antisense oligonucleotides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo